Long-Term Liabilities to Equity: Lifeward Ltd. (LFWD)

Official company branding of Lifeward Ltd. (LFWD)

ReWalk Robotics Ltd. (LFWD) dominates the robotic mobility restoration segment, protecting its niche through actuator patents and insurance barriers; this chart on GURU.Markets demonstrates the 0.83 metric. The business exhibits low cyclicality, as the demand for exoskeletons is health-driven, although clinic procurement depends on government budgets. Revenue growth is currently stimulated by the expansion of Medicare programs, while international expansion remains a promising driver.

ReWalk Robotics Ltd (LFWD): Long-Term Debt to Capital from 02/21/2024 to 10/27/2026
Core merchandise of ReWalk Robotics Ltd.

For ReWalk Robotics Ltd. (LFWD), the long-term debt-to-equity ratio serves as an indicator of long-term financial stability. This metric compares loans with maturities exceeding one year against shareholders' equity. An increasing ratio signals rising leverage, while a decrease reflects a conservative approach to borrowing. During the expansion phase of exoskeletons and the scaling of B2B sales, this balance determines the liquidity available for development. An optimal proportion provides the resources for growth without risking insolvency.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio IRADIMED CORPORATION|EMBC - Long-Term Liabilities to Equity|Long-Term Debt to Capital TNDM|AxoGen Inc (AXGN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital SI-BONE Corp (SIBN)|Long-Term Debt to Capital Ratio Orthofix Corp (OFIX)|Bioventus Inc. (BVS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient KIDS (orthopediatrics.com)|Treace Medical Concepts, Inc. - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Blade Air Mobility SRTA|CARL (Carlsmed Corp) - Long-Term Debt to Capital|RXST - Long-Term Liabilities to Capital|Long-Term Debt to Capital clearpointneuro.com|stereotaxis.com (STXS) - Long-Term Debt to Capital Ratio|STIM: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Sight Sciences Inc.|Long-Term Debt to Capital OBIO (Orchestra BioMed)|Long-Term Debt to Equity Ratio anikatherapeutics.com (ANIK)|Long-Term Debt to Capital NSPR (InspireMD, Inc.)|Jin Medical International Ltd. - Long-Term Debt to Capital|VANI - Long-Term Debt to Equity|Xtant Medical Holdings (XTNT) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio NeuroOne Corp NMTC|Modular Medical, Inc. (MODD) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital MYO (Myomo, Inc.)|Long-Term Liabilities to Capital COCH|VVOS: Long-Term Debt to Equity|Long-Term Indebtedness to Equity enVVeno Medical Corporation NVNO|Long-Term Debt to Equity Ratio SINT (Sintx Technologies, Inc.)|Long-Term Debt to Capital Tenon Medical Inc TNON|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)